Research progress on risk factors for in-stent restenosis following cerebrovascular stent implantation. [PDF]
Gao H +6 more
europepmc +1 more source
Association of serum total bilirubin with recurrent cardiovascular events in patients with in-stent restenosis: a stratified analysis by inflammatory status. [PDF]
Yu M +8 more
europepmc +1 more source
Intravascular Brachytherapy for In-Stent Restenosis in Patients With Chronic Kidney Disease. [PDF]
Sella G +11 more
europepmc +1 more source
Unveiling a Hidden Threat: Wellens Syndrome as a Manifestation of Critical In-Stent Restenosis. [PDF]
Sousou JM +4 more
europepmc +1 more source
A rare optical coherence tomography finding of a striped, low-attenuation plaque protruding into the lumen in in-stent restenosis. [PDF]
Otaka N, Matsusaka H, Morishige K.
europepmc +1 more source
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial. [PDF]
Jamil Y +18 more
europepmc +1 more source
Dense Calcification of the Common Femoral Artery Is Protective Against In-Stent Restenosis. [PDF]
Bamdé CC +5 more
europepmc +1 more source
SMPD1-mediated sphingolipid metabolism dysregulation in predicting and preventing in-stent restenosis of coronary heart disease patients. [PDF]
Meng W +12 more
europepmc +1 more source
Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis. [PDF]
Kritya M +11 more
europepmc +1 more source

